Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
Acta Pharmaceutica Sinica. B|May 15, 2025
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitorsXiong Zhang, Yatian Yang, Hongye Zou, et al.
Cancer Research|February 22, 2014
Androgen receptor splice variants determine taxane sensitivity in prostate cancerMaria Thadani-Mulero, Luigi Portella, Shihua Sun, et al.
Oncogene|November 25, 2025
Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancerYongtao Li, Zhicheng Zhou, Yiqun Zhang, et al.
Cancer Research|June 28, 2014
AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasisJuanJuan Yin, Yen-Nien Liu, Heather Tillman, et al.
Molecular Cancer Research : MCR|May 4, 2017
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155Michael D Nyquist, Alexandra Corella, John Burns, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 2012
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy SeriesColm Morrissey, Martine P Roudier, Alex Dowell, et al.
Urology|October 20, 2004
Metastases of prostate cancer express estrogen receptor-betaJanice S Lai, Lisha G Brown, Lawrence D True, et al.
Cancer Research|March 6, 2023
LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate CancerMuqing Li, Mingyu Liu, Wanting Han, et al.
Clinical & Experimental Metastasis|November 19, 2013
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironmentSandy R Larson, Jessica Chin, Xiaotun Zhang, et al.
Cancer Letters|February 8, 2021
Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapyTianfang Ma, Shanshan Bai, Yanfeng Qi, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Acta Pharmaceutica Sinica. B|May 15, 2025
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitorsXiong Zhang, Yatian Yang, Hongye Zou, et al.
Cancer Research|February 22, 2014
Androgen receptor splice variants determine taxane sensitivity in prostate cancerMaria Thadani-Mulero, Luigi Portella, Shihua Sun, et al.
Oncogene|November 25, 2025
Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancerYongtao Li, Zhicheng Zhou, Yiqun Zhang, et al.
Cancer Research|June 28, 2014
AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasisJuanJuan Yin, Yen-Nien Liu, Heather Tillman, et al.
Molecular Cancer Research : MCR|May 4, 2017
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155Michael D Nyquist, Alexandra Corella, John Burns, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 2012
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy SeriesColm Morrissey, Martine P Roudier, Alex Dowell, et al.
Urology|October 20, 2004
Metastases of prostate cancer express estrogen receptor-betaJanice S Lai, Lisha G Brown, Lawrence D True, et al.
Cancer Research|March 6, 2023
LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate CancerMuqing Li, Mingyu Liu, Wanting Han, et al.
Clinical & Experimental Metastasis|November 19, 2013
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironmentSandy R Larson, Jessica Chin, Xiaotun Zhang, et al.
Cancer Letters|February 8, 2021
Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapyTianfang Ma, Shanshan Bai, Yanfeng Qi, et al.
Pageof 23